RAPP
RAPPORT THERA (RAPP)
NASDAQ
$38.50+$3.60 (+10.31%)
Price as of Jun 03, 2026 5:14 PM EDT
  • $1.9B
    Market Cap
  • 185.13%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
69,000
N/A
Gross Profit
0
+100.00%
-69,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-94.8M
+55.56%
-60.9M
N/A
Depreciation and Amortization Expense
1.0M
+21.22%
839,000
N/A
Total Operating Expenses
125.1M
+50.62%
83.1M
N/A
Operating Profit
-125.1M
+50.62%
-83.1M
N/A
Interest Income
13.6M
+12.18%
12.1M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
13.6M
+12.18%
12.1M
N/A
Total Nonoperating Income and Expense
13.6M
+186.77%
4.7M
N/A
Income before Taxes
-125.1M
+59.75%
-78.3M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
0
N/A
0
N/A
Net Income
-111.5M
+42.37%
-78.3M
N/A
Net Income from Continuing Operations Applicable to Common
-111.5M
+42.37%
-78.3M
N/A
Basic EPS and Net Income
-2.86
-24.34%
-3.78
N/A
Diluted EPS and Net Income
-2.86
-24.34%
-3.78
N/A
Basic Weighted Average Shares
38.9M
+87.74%
20.7M
N/A
Diluted Weighted Average Shares
38.9M
+87.74%
20.7M
N/A
Balance Sheet
Cash and Cash Equivalents
52.6M
-7.32%
56.8M
N/A
Short-Term Investments
437.9M
+76.23%
248.5M
N/A
Cash and Cash Equivalents and Short-Term Investments
490.5M
+60.68%
305.3M
N/A
Total Current Assets
498.6M
+60.93%
309.8M
N/A
Accumulated Depreciation
2.0M
+105.39%
965,000
N/A
Property and Plant and Equipment and Net
3.0M
-15.67%
3.5M
N/A
Total Long-Term Assets
985,000
+515.63%
160,000
N/A
Total Assets
512.4M
+62.71%
314.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
19.0M
+117.28%
8.8M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
8.7M
+1,081.19%
739,000
N/A
Total Liabilities
27.8M
+192.22%
9.5M
N/A
Retained Earnings
-235.2M
+90.09%
-123.7M
N/A
Total Stockholders Equity
484.7M
+58.68%
305.4M
N/A
Total Shares Outstanding
47.8M
+30.60%
36.6M
N/A
Cash Flow
Cash from Operating Activities
-87.5M
+34.93%
-64.8M
N/A
Capital Expenditures
616,000
-74.39%
2.4M
N/A
Cash from Investing Activities
-187.5M
+10.19%
-170.1M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
270.8M
+22.18%
221.6M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-26.95%
N/A
N/A
N/A
Return on Equity
-28.22%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
26.17
N/A
N/A
N/A
Cash Ratio
2.76
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow